Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.

[1]  B. Vandermeer,et al.  Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT) , 2020, Critical Care.

[2]  Dennis H. Murphree,et al.  Early noncardiovascular organ failure and mortality in the cardiac intensive care unit , 2020, Clinical cardiology.

[3]  Dennis H. Murphree,et al.  Predictive Value of the Get With The Guidelines Heart Failure Risk Score in Unselected Cardiac Intensive Care Unit Patients , 2020, Journal of the American Heart Association.

[4]  D. Morrow,et al.  Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry. , 2020, American heart journal.

[5]  D. Lenihan,et al.  Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial. , 2019, JACC. Heart failure.

[6]  K. Kashani,et al.  Hypotension within one-hour from starting CRRT is associated with in-hospital mortality. , 2019, Journal of critical care.

[7]  R. Bellomo,et al.  Acute kidney injury , 2019, The Lancet.

[8]  K. Kashani,et al.  Short, and long-term mortality among cardiac intensive care unit patients started on continuous renal replacement therapy. , 2019, Journal of critical care.

[9]  M. Vaduganathan,et al.  Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. , 2019, The Canadian journal of cardiology.

[10]  A. Jaffe,et al.  Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population. , 2019, American heart journal.

[11]  C. Granger,et al.  Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness. , 2019, JAMA cardiology.

[12]  Javier A. Neyra,et al.  Fluid Overload Associates With Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy. , 2019, Critical care medicine.

[13]  Dennis H. Murphree,et al.  Derivation and Validation of a Novel Cardiac Intensive Care Unit Admission Risk Score for Mortality , 2019, Journal of the American Heart Association.

[14]  K. Kashani,et al.  Role of Loop Diuretic Challenge in Stage 3 Acute Kidney Injury. , 2019, Mayo Clinic proceedings.

[15]  S. Bagshaw,et al.  The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study. , 2019, Journal of critical care.

[16]  Xiao-lu Ma,et al.  Risk factors for acute kidney injury in patients with acute myocardial infarction , 2019, Chinese medical journal.

[17]  S. van Diepen,et al.  Noncardiovascular Disease and Critical Care Delivery in a Contemporary Cardiac and Medical Intensive Care Unit , 2019, Journal of intensive care medicine.

[18]  G. Clermont,et al.  Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration , 2019, JAMA network open.

[19]  G. Regolisti,et al.  A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy , 2019, Antimicrobial Agents and Chemotherapy.

[20]  C. Ronco,et al.  Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[21]  D. Gommers,et al.  Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study , 2019, BMC Nephrology.

[22]  K. Kashani,et al.  Hyperkalemia Is Associated With Increased Mortality Among Unselected Cardiac Intensive Care Unit Patients , 2019, Journal of the American Heart Association.

[23]  N. Pannu,et al.  Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury , 2018, JAMA internal medicine.

[24]  Yi-chun Cheng,et al.  Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis , 2018, BMC Nephrology.

[25]  C. Chung,et al.  Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury , 2018, Critical Care.

[26]  Y. K. Kee,et al.  Factors Associated with Early Mortality in Critically Ill Patients Following the Initiation of Continuous Renal Replacement Therapy , 2018, Journal of clinical medicine.

[27]  A. Kuriyama,et al.  Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis , 2018, Heart Failure Reviews.

[28]  Lisa E. Vaughan,et al.  End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[29]  G. Nadkarni,et al.  National Trends and Outcomes in Dialysis-Requiring Acute Kidney Injury in Heart Failure: 2002-2013. , 2018, Journal of cardiac failure.

[30]  G. Jian,et al.  Is the mean platelet volume a predictive marker of a high in-hospital mortality of acute cardiorenal syndrome patients receiving continuous renal replacement therapy? , 2018, Medicine.

[31]  A. Mebazaa,et al.  Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury , 2018, Intensive Care Medicine.

[32]  S. Bagshaw,et al.  Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials , 2018, PloS one.

[33]  J. Kellum,et al.  Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial) , 2018, Critical Care.

[34]  T. Yoo,et al.  Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy , 2018, PloS one.

[35]  N. Bansal,et al.  Outcomes Associated With Left Ventricular Assist Devices Among Recipients With and Without End-stage Renal Disease , 2017, JAMA internal medicine.

[36]  R. Bellomo,et al.  Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  Miyeun Han,et al.  The role of the specialized team in the operation of continuous renal replacement therapy: a single-center experience , 2017, BMC Nephrology.

[38]  G. Clermont,et al.  Intensive Monitoring of Urine Output Is Associated With Increased Detection of Acute Kidney Injury and Improved Outcomes , 2017, Chest.

[39]  D. Nash,et al.  Systematic review and meta‐analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit , 2017, Journal of critical care.

[40]  K. Kashani,et al.  Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study , 2017, PloS one.

[41]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.

[42]  Zhe Luo,et al.  A comparison of early versus late initiation of renal replacement therapy for acute kidney injury in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials , 2017, BMC Nephrology.

[43]  A. Abdo.  Diagnosis and Management of Heart Failure in Long-Term Dialysis Patients , 2017, Current Heart Failure Reports.

[44]  M. Sjoding,et al.  Changes in Primary Noncardiac Diagnoses Over Time Among Elderly Cardiac Intensive Care Unit Patients in the United States , 2017, Circulation. Cardiovascular quality and outcomes.

[45]  Alistair E. W. Johnson,et al.  Right Ventricular Function, Peripheral Edema, and Acute Kidney Injury in Critical Illness , 2017, Kidney international reports.

[46]  L. Hartling,et al.  Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review , 2017, Intensive Care Medicine.

[47]  Jenq-Wen Huang,et al.  Factors associated with poor outcomes of continuous renal replacement therapy , 2017, PloS one.

[48]  G. Fonarow,et al.  Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure , 2017, Journal of the American College of Cardiology.

[49]  Travis J Moss,et al.  Acute Noncardiovascular Illness in the Cardiac Intensive Care Unit. , 2017, Journal of the American College of Cardiology.

[50]  F. Veglia,et al.  Renal replacement therapy in patients with acute myocardial infarction: Rate of use, clinical predictors and relationship with in-hospital mortality. , 2017, International journal of cardiology.

[51]  Dionne A. Graham,et al.  A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[52]  S. de Servi,et al.  Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis , 2017, PloS one.

[53]  C. Kwok,et al.  Ultrafiltration for acute decompensated cardiac failure: A systematic review and meta-analysis. , 2017, International journal of cardiology.

[54]  Weihong Zhao,et al.  Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials , 2017, Scientific Reports.

[55]  Rajit K. Basu,et al.  Optimal Role of the Nephrologist in the Intensive Care Unit , 2016, Blood Purification.

[56]  J. Kellum,et al.  The 17th Acute Disease Quality Initiative International Consensus Conference: Introducing Precision Renal Replacement Therapy , 2016, Blood Purification.

[57]  K. Anstrom,et al.  Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). , 2016, Circulation. Heart failure.

[58]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[59]  Bicheng Liu,et al.  Risk factors of acute kidney injury after acute myocardial infarction , 2016, Renal failure.

[60]  E. Michalets,et al.  Midodrine for the weaning of vasopressor infusions , 2016, Journal of clinical pharmacy and therapeutics.

[61]  J. Kellum,et al.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. , 2016, JAMA.

[62]  F. Tubach,et al.  Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. , 2016, The New England journal of medicine.

[63]  D. Needham,et al.  Feasibility and Safety of Physical Therapy during Continuous Renal Replacement Therapy in the Intensive Care Unit. , 2016, Annals of the American Thoracic Society.

[64]  G. Fonarow,et al.  Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure. , 2016, JACC. Heart failure.

[65]  J. Kellum,et al.  Acute Kidney Injury in Cardiorenal Syndrome Type 1 Patients: A Systematic Review and Meta-Analysis , 2015, Cardiorenal Medicine.

[66]  H. Bøtker,et al.  Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study , 2015, Critical Care.

[67]  B. Zhu,et al.  Fluid balance and mortality in critically ill patients with acute kidney injury: a multicenter prospective epidemiological study , 2015, Critical Care.

[68]  L. Chawla,et al.  A Clinical Approach to the Acute Cardiorenal Syndrome. , 2015, Critical care clinics.

[69]  T. Slowinski,et al.  Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study , 2015, Critical Care.

[70]  A. Garg,et al.  Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study , 2015, BMC Nephrology.

[71]  R. Bellomo,et al.  A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults* , 2015, Critical care medicine.

[72]  Rinaldo Bellomo,et al.  Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study , 2015, Intensive Care Medicine.

[73]  J. Pugin,et al.  Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial , 2015, Critical Care.

[74]  J. Nally,et al.  Renal failure requiring dialysis complicating slow continuous ultrafiltration in acute heart failure: importance of systolic perfusion pressure. , 2015, Journal of cardiac failure.

[75]  Jian-Xin Zhou,et al.  Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review , 2014, Critical Care.

[76]  Guisen Li,et al.  Relationship of cystatin‐C change and the prevalence of death or dialysis need after acute kidney injury: A meta‐analysis , 2014, Nephrology.

[77]  T. Yoo,et al.  The benefit of specialized team approaches in patients with acute kidney injury undergoing continuous renal replacement therapy: propensity score matched analysis , 2014, Critical Care.

[78]  Susan F. Klaus,et al.  Early mobility activities during continuous renal replacement therapy. , 2014, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[79]  L. Forni,et al.  Biomarkers in Cardiorenal Syndrome , 2014, Blood Purification.

[80]  W. Mosleh,et al.  Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. , 2014, International journal of cardiology.

[81]  G. Filippatos,et al.  Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. , 2014, International journal of cardiology.

[82]  Adrian F Hernandez,et al.  Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. , 2013, JAMA.

[83]  D. Kolte,et al.  Trends in acute kidney injury and outcomes after early percutaneous coronary intervention in patients ≥75 years of age with acute myocardial infarction. , 2013, The American journal of cardiology.

[84]  J. Kellum,et al.  Current Use of Biomarkers in Acute Kidney Injury: Report and Summary of Recommendations from the 10th Acute Dialysis Quality Initiative Consensus Conference , 2013, Kidney international.

[85]  P. Kimmel,et al.  Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury , 2013, Critical Care.

[86]  L. Forni,et al.  Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury , 2013, Critical care medicine.

[87]  P. Murray,et al.  A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure , 2013, Cardiorenal Medicine.

[88]  C. Ronco,et al.  Fluid balance and urine volume are independent predictors of mortality in acute kidney injury , 2013, Critical Care.

[89]  K. Anstrom,et al.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome. , 2012, The New England journal of medicine.

[90]  Ognjen Gajic,et al.  Risk Factors for Development of Acute Kidney Injury in Critically Ill Patients: A Systematic Review and Meta-Analysis of Observational Studies , 2012, Critical care research and practice.

[91]  R. Starling,et al.  Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. , 2012, Journal of the American College of Cardiology.

[92]  R. Fischer,et al.  Long-term outcomes of survivors of ICU acute kidney injury requiring renal replacement therapy: a 10-year prospective cohort study , 2012, Clinical kidney journal.

[93]  M. Böhm,et al.  Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients , 2012, Critical Care.

[94]  Section 5: Dialysis Interventions for Treatment of AKI , 2012, Kidney international supplements.

[95]  Summary of Recommendation Statements , 2012, Kidney international supplements.

[96]  Adrian F. Hernandez,et al.  Combination of loop diuretics with thiazide-type diuretics in heart failure. , 2010, Journal of the American College of Cardiology.

[97]  B. Mueller,et al.  Challenges in Developing Evidence‐Based Drug Dosing Guidelines for Adults and Children Receiving Renal Replacement Therapy , 2009, Clinical pharmacology and therapeutics.

[98]  R. Bellomo,et al.  Discontinuation of continuous renal replacement therapy: A post hoc analysis of a prospective multicenter observational study* , 2009, Critical care medicine.

[99]  R. Danner,et al.  Continuous-Infusion β-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria , 2009, The Annals of pharmacotherapy.

[100]  G. Navis,et al.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.

[101]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[102]  M. Kuiper,et al.  Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: A double blind randomized controlled trial* , 2009, Critical care medicine.

[103]  O. Gajic,et al.  Intermittent Hemodialysis Versus Continuous Renal Replacement Therapy for Acute Renal Failure in the Intensive Care Unit: An Observational Outcomes Analysis , 2008, Journal of intensive care medicine.

[104]  M. Schetz.  Drug dosing in continuous renal replacement therapy: general rules , 2007, Current opinion in critical care.

[105]  K. Swedberg,et al.  Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. , 2007, JAMA.

[106]  K. Swedberg,et al.  Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. , 2007, JAMA.

[107]  P. Palevsky.  UNRESOLVED ISSUES IN DIALYSIS: Dialysis Modality and Dosing Strategy in Acute Renal Failure , 2006 .

[108]  E. Villar,et al.  Chronic renal failure and end-stage renal disease are associated with a high rate of mortality after heart transplantation. , 2005, Transplantation proceedings.

[109]  D. Fliser,et al.  Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[110]  J. Kellum,et al.  Use of dopamine in acute renal failure: A meta-analysis , 2001, Critical care medicine.

[111]  R. Schmieder,et al.  Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[112]  K. Okeie,et al.  Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration , 2000, Intensive Care Medicine.

[113]  T. Depner,et al.  Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[114]  P. Ferdinande,et al.  Pharmacokinetics of continuous renal replacement therapy , 1995, Intensive Care Medicine.

[115]  M. Guazzi,et al.  Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. , 1994, British heart journal.

[116]  P. Agostoni,et al.  Isolated ultrafiltration in moderate congestive heart failure. , 1993, Journal of the American College of Cardiology.

[117]  W. Henrich,et al.  Role of osmolality in blood pressure stability after dialysis and ultrafiltration. , 1980, Kidney international.

[118]  P. Marik.  Acute Kidney Injury , 2015 .

[119]  J. Kellum,et al.  Pathophysiology of the Cardiorenal Syndromes: Executive Summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) , 2014, Blood Purification.

[120]  Yen-Hung Lin,et al.  Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy , 2007, Intensive Care Medicine.

[121]  R. Bellomo,et al.  Severe acute renal failure: a comparison of acute continuous hemodiafiltration and conventional dialytic therapy. , 1995, Nephron.